Eptinezumab for chronic headache in IIH
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests an IV treatment called eptinezumab to see if it reduces chronic headaches in people with increased pressure around the brain (IIH). It may help if you have many headache days and meet the other criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 55 years old.
- You have been diagnosed with Idiopathic Intracranial Hypertension (pressure in the head) and have chronic headaches from it.
- You have at least 15 headache days per month and at least 8 migraine-like days per month.
- You will use effective birth control during the trial and for 5 months after the last dose (if you could become pregnant).
- You have not taken anti-CGRP antibody treatments (like certain migraine injections) very recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide can help lower the pressure inside your skull caused by a condition called Idiopathic Intracranial Hypertension. It's designed for people with a BMI of 30 or higher who have swelling of the optic nerve.
This trial tests whether placing a stent (a small tube) in a narrowed brain vein can help reduce pressure in the head in people with Intracranial Hypertension who have been on acetazolamide for over a year. It may be an option if you still have high pressure despite medication.
This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.
This study looks at how body weight (BMI) affects how well people with Idiopathic Intracranial Hypertension (IIH) respond to treatment. It may help doctors understand if weight influences symptom relief.
This trial tests whether giving eptinezumab (an antibody that blocks a pain protein) soon after a head injury can reduce the severity and duration of headaches that start after trauma. If you've had new or worsening headaches within the past 8 weeks after a head injury, this treatment might help prevent them from becoming chronic.
This trial tests eptinezumab, a preventive medicine, to reduce headache frequency in teens with chronic migraine. It may help your teen if they have frequent migraine days despite usual care.
Hear when a new Idiopathic Intracranial Hypertension (IIH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.